<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:0fa91957-3be9-46eb-b299-c64726ab29b8,g:54959551-51d6-4058-9de7-5561dedcaa94-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="vrdn-20251231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bb1d82ec-a562-4d51-b9e3-12a44a061c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cd50cbbc-3c36-49a7-9e23-6966850bc895" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb1d82ec-a562-4d51-b9e3-12a44a061c4b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cd50cbbc-3c36-49a7-9e23-6966850bc895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_fc910ae1-dfb4-41d3-95bc-dcaf72314af1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_bb1d82ec-a562-4d51-b9e3-12a44a061c4b" xlink:to="loc_us-gaap_AccountsPayableCurrent_fc910ae1-dfb4-41d3-95bc-dcaf72314af1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e2f7eec2-3871-419e-8528-17d997e3978b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d5cdb4c7-23e4-441c-b859-46b71f19cdec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e2f7eec2-3871-419e-8528-17d997e3978b" xlink:to="loc_us-gaap_LiabilitiesCurrent_d5cdb4c7-23e4-441c-b859-46b71f19cdec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_1c3ba9ae-b7f5-48cc-af50-7a4cb74f13d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e2f7eec2-3871-419e-8528-17d997e3978b" xlink:to="loc_us-gaap_SecuredLongTermDebt_1c3ba9ae-b7f5-48cc-af50-7a4cb74f13d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_3153c7b8-b602-4291-b6bd-b40da78351a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e2f7eec2-3871-419e-8528-17d997e3978b" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_3153c7b8-b602-4291-b6bd-b40da78351a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_019c6bc8-570c-73d5-9123-aae22bb0b8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e2f7eec2-3871-419e-8528-17d997e3978b" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_019c6bc8-570c-73d5-9123-aae22bb0b8f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019c6bc0-532f-76be-b0e7-53947180bb21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_e2f7eec2-3871-419e-8528-17d997e3978b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019c6bc0-532f-76be-b0e7-53947180bb21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e02ee8e4-2de7-478b-9a9d-f5c5092f158a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_80944a5f-c01b-433f-9823-f9cd5ce07afb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e02ee8e4-2de7-478b-9a9d-f5c5092f158a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_80944a5f-c01b-433f-9823-f9cd5ce07afb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e1dc151d-53b0-494e-b4ad-f0f6de8c77e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e02ee8e4-2de7-478b-9a9d-f5c5092f158a" xlink:to="loc_us-gaap_StockholdersEquity_e1dc151d-53b0-494e-b4ad-f0f6de8c77e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5ae905b6-773c-4f9b-b537-764285dd4309" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e02ee8e4-2de7-478b-9a9d-f5c5092f158a" xlink:to="loc_us-gaap_Liabilities_5ae905b6-773c-4f9b-b537-764285dd4309" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_06d1076a-2d0f-4f79-ae4f-1ff045f8fff2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e459aa26-b74b-45d2-b7dc-ba70795635da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06d1076a-2d0f-4f79-ae4f-1ff045f8fff2" xlink:to="loc_us-gaap_AssetsCurrent_e459aa26-b74b-45d2-b7dc-ba70795635da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_83fa7860-58d6-46e8-8af7-5e015d428b87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06d1076a-2d0f-4f79-ae4f-1ff045f8fff2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_83fa7860-58d6-46e8-8af7-5e015d428b87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b8ef68b1-7bde-43ed-81ee-d55808182549" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06d1076a-2d0f-4f79-ae4f-1ff045f8fff2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b8ef68b1-7bde-43ed-81ee-d55808182549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_89dbe496-4e8b-4a8e-a69d-b12b2fa7fba5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_06d1076a-2d0f-4f79-ae4f-1ff045f8fff2" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_89dbe496-4e8b-4a8e-a69d-b12b2fa7fba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f4a21bfa-c07d-41a0-8d5b-fc0ac4d93f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_056b9cff-1b7b-4924-b928-ff98d206fe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4a21bfa-c07d-41a0-8d5b-fc0ac4d93f1a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_056b9cff-1b7b-4924-b928-ff98d206fe0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b5ab44bd-644e-4255-973e-8dcc48134e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4a21bfa-c07d-41a0-8d5b-fc0ac4d93f1a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b5ab44bd-644e-4255-973e-8dcc48134e7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f762a3a2-0509-4fd0-bf26-3050de3d0971" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f4a21bfa-c07d-41a0-8d5b-fc0ac4d93f1a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_f762a3a2-0509-4fd0-bf26-3050de3d0971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_60f1c6d7-18a2-4191-84ef-c76a4d051c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ef9daf8e-d4e3-4818-962f-5ca45ddddd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_60f1c6d7-18a2-4191-84ef-c76a4d051c6a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ef9daf8e-d4e3-4818-962f-5ca45ddddd7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0185d6ad-ade6-4c92-bafb-5fcf3fab4ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_60f1c6d7-18a2-4191-84ef-c76a4d051c6a" xlink:to="loc_us-gaap_PreferredStockValue_0185d6ad-ade6-4c92-bafb-5fcf3fab4ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_28262948-e49c-4c87-a84c-7b1cc724df2e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_60f1c6d7-18a2-4191-84ef-c76a4d051c6a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_28262948-e49c-4c87-a84c-7b1cc724df2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9de9b630-d678-41a6-92ea-7d2a8cead9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_60f1c6d7-18a2-4191-84ef-c76a4d051c6a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9de9b630-d678-41a6-92ea-7d2a8cead9c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7402adc3-2f84-4b73-8d0c-fd32c3119b52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_60f1c6d7-18a2-4191-84ef-c76a4d051c6a" xlink:to="loc_us-gaap_CommonStockValue_7402adc3-2f84-4b73-8d0c-fd32c3119b52" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="vrdn-20251231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2a65e5a0-2189-4ab8-8d34-a9c08bfc2766" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_19984f7e-e53a-4eb8-9eb2-e1d44e41d32a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2a65e5a0-2189-4ab8-8d34-a9c08bfc2766" xlink:to="loc_us-gaap_OperatingExpenses_19984f7e-e53a-4eb8-9eb2-e1d44e41d32a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_31e78923-0936-4e08-badd-3ac92d1b7136" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2a65e5a0-2189-4ab8-8d34-a9c08bfc2766" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_31e78923-0936-4e08-badd-3ac92d1b7136" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4f6d4c1b-8bd7-4ce3-a594-0a246b975693" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2d95c648-fbc8-42b2-8a8d-38900dcdda12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4f6d4c1b-8bd7-4ce3-a594-0a246b975693" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2d95c648-fbc8-42b2-8a8d-38900dcdda12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_55ced047-5eac-446d-bd2a-2005ae1fb21b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_58d7f7fe-0c22-47d4-a79e-13eb7514f871" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_55ced047-5eac-446d-bd2a-2005ae1fb21b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_58d7f7fe-0c22-47d4-a79e-13eb7514f871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_755d26ee-3249-46b1-8761-1a3659b7e5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_55ced047-5eac-446d-bd2a-2005ae1fb21b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_755d26ee-3249-46b1-8761-1a3659b7e5ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_907a46fc-6f2a-4597-ba38-06e85f80f385" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2ff69574-3e62-4fb4-8f61-44b301564cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_907a46fc-6f2a-4597-ba38-06e85f80f385" xlink:to="loc_us-gaap_OperatingIncomeLoss_2ff69574-3e62-4fb4-8f61-44b301564cdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_19dabc19-d98f-4757-b620-c6fd90cc39e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_907a46fc-6f2a-4597-ba38-06e85f80f385" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_19dabc19-d98f-4757-b620-c6fd90cc39e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_157fb094-b427-45b3-842c-d283458e6071" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d75598b2-454a-4a5c-be5f-bcedb28ae298" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_157fb094-b427-45b3-842c-d283458e6071" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d75598b2-454a-4a5c-be5f-bcedb28ae298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_13efe45e-06b3-4240-837e-199fb89daffa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_157fb094-b427-45b3-842c-d283458e6071" xlink:to="loc_us-gaap_NetIncomeLoss_13efe45e-06b3-4240-837e-199fb89daffa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_8e794191-ff71-4626-8fd1-da7566ca35ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_96401d8f-8b71-4e8f-a0ca-a2e0b6230b96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_8e794191-ff71-4626-8fd1-da7566ca35ad" xlink:to="loc_us-gaap_InvestmentIncomeInterest_96401d8f-8b71-4e8f-a0ca-a2e0b6230b96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_c066330a-2361-4fd6-a356-07b456b3d39b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_8e794191-ff71-4626-8fd1-da7566ca35ad" xlink:to="loc_us-gaap_InterestExpenseNonoperating_c066330a-2361-4fd6-a356-07b456b3d39b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_a23a94c0-d45f-4080-ade3-928fdd141904" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_8e794191-ff71-4626-8fd1-da7566ca35ad" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_a23a94c0-d45f-4080-ade3-928fdd141904" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="vrdn-20251231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_744165e7-45b8-4271-ab57-206890b49556" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_460c3292-a9ff-482e-80f4-4f244612ba77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_744165e7-45b8-4271-ab57-206890b49556" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_460c3292-a9ff-482e-80f4-4f244612ba77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b30e26d9-32d6-44c6-a98a-4b095604a9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_744165e7-45b8-4271-ab57-206890b49556" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_b30e26d9-32d6-44c6-a98a-4b095604a9a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ec79d2a2-5592-4715-bc1d-5c0148c41557" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_744165e7-45b8-4271-ab57-206890b49556" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ec79d2a2-5592-4715-bc1d-5c0148c41557" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c1803914-7ac7-4e2a-bbc9-b47c0726dbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_NetIncomeLoss_c1803914-7ac7-4e2a-bbc9-b47c0726dbd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5cc3402c-5996-4f19-a491-cb78b370fa1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_ShareBasedCompensation_5cc3402c-5996-4f19-a491-cb78b370fa1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_261629e3-b47d-4078-8ab5-12186840fd08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_261629e3-b47d-4078-8ab5-12186840fd08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_013db423-8e93-4a43-8a81-c98b7b197bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_PaidInKindInterest_013db423-8e93-4a43-8a81-c98b7b197bb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5535a16b-d5ca-46f8-8cb1-b39bfc2ff8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5535a16b-d5ca-46f8-8cb1-b39bfc2ff8bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_DerivativeLiabilityIssuanceCosts_5c308c78-76f1-43b6-b0ba-01256fad4146" xlink:href="vrdn-20251231.xsd#vrdn_DerivativeLiabilityIssuanceCosts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_vrdn_DerivativeLiabilityIssuanceCosts_5c308c78-76f1-43b6-b0ba-01256fad4146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_f7b486d1-f07d-4196-a405-696afacad66e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_f7b486d1-f07d-4196-a405-696afacad66e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_6eda29a5-ace0-46aa-8bdc-7f80d7e4154d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_6eda29a5-ace0-46aa-8bdc-7f80d7e4154d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_3f263c30-a204-4929-8f72-115573d0b421" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_3f263c30-a204-4929-8f72-115573d0b421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a8c0f5aa-5b3a-4008-8a7f-4feb82c2d282" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a8c0f5aa-5b3a-4008-8a7f-4feb82c2d282" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7c6d65fd-7986-4595-859e-840f64ab5cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7c6d65fd-7986-4595-859e-840f64ab5cb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_749a557a-3124-434f-acb5-f771e0147b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_089f57df-8823-4377-aa99-8971a4089fbb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_749a557a-3124-434f-acb5-f771e0147b43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd270109-56b7-4088-a9fa-5030ce8070eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3130646-cf8e-4c7f-bbf0-b42c70febb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd270109-56b7-4088-a9fa-5030ce8070eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3130646-cf8e-4c7f-bbf0-b42c70febb6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f9988a0a-c1bb-4baf-acd5-bb81dfc86289" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd270109-56b7-4088-a9fa-5030ce8070eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f9988a0a-c1bb-4baf-acd5-bb81dfc86289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7e79d0f6-9546-4f6d-bd31-5cdde190d0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fd270109-56b7-4088-a9fa-5030ce8070eb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7e79d0f6-9546-4f6d-bd31-5cdde190d0e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_297023e2-ef81-4248-8049-4731f15aded6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_297023e2-ef81-4248-8049-4731f15aded6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_733b7263-3bb6-43d1-bc77-0ab48ea64125" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_733b7263-3bb6-43d1-bc77-0ab48ea64125" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_a12d4678-e28f-4dec-a87d-2aaa4e9ee00a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_a12d4678-e28f-4dec-a87d-2aaa4e9ee00a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_c91e5619-03f2-4918-9508-95aceeabf46e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_c91e5619-03f2-4918-9508-95aceeabf46e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_22e4ab62-89d2-49cc-b514-c232be6a88dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_22e4ab62-89d2-49cc-b514-c232be6a88dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b8863427-b4ef-4fa5-bdf2-2edeeda5253b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b8863427-b4ef-4fa5-bdf2-2edeeda5253b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_431c123b-f7cd-4a36-a55c-76a226ea05d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_431c123b-f7cd-4a36-a55c-76a226ea05d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_9a9c63ac-7afb-4d73-864b-629b821072f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_9a9c63ac-7afb-4d73-864b-629b821072f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_PaymentOfIssuanceCostsSaleOfFutureRevenue_baf143df-ff94-4c76-9385-a1e04f70ff8d" xlink:href="vrdn-20251231.xsd#vrdn_PaymentOfIssuanceCostsSaleOfFutureRevenue"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_vrdn_PaymentOfIssuanceCostsSaleOfFutureRevenue_baf143df-ff94-4c76-9385-a1e04f70ff8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c18a98bc-3905-4223-9eda-319eb68e7e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c18a98bc-3905-4223-9eda-319eb68e7e8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_019c6ce1-8b9e-781b-9662-8255751d1256" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1da6d96f-147b-44eb-8197-c04f9b3d0a47" xlink:to="loc_us-gaap_ProceedsFromStockPlans_019c6ce1-8b9e-781b-9662-8255751d1256" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_02524a8d-da8b-4d5d-bcb9-1a3ec75eca20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_fbbd832f-89b2-4f55-aa22-acf61bb71a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_02524a8d-da8b-4d5d-bcb9-1a3ec75eca20" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_fbbd832f-89b2-4f55-aa22-acf61bb71a9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5ed6a7bc-dd3d-486f-9438-f3af65d95a57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_02524a8d-da8b-4d5d-bcb9-1a3ec75eca20" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5ed6a7bc-dd3d-486f-9438-f3af65d95a57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1329393e-aef6-43a6-9561-d26e15f224ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_02524a8d-da8b-4d5d-bcb9-1a3ec75eca20" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1329393e-aef6-43a6-9561-d26e15f224ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_62ef59be-844f-40f5-91b0-01a7a36ecbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b98a923e-a704-463a-a491-b62cbb9e1b23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_62ef59be-844f-40f5-91b0-01a7a36ecbb0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b98a923e-a704-463a-a491-b62cbb9e1b23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1612b116-e617-435b-945e-efc08a0b0146" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_62ef59be-844f-40f5-91b0-01a7a36ecbb0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1612b116-e617-435b-945e-efc08a0b0146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019c773e-a50a-7098-91c9-15853272c3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_019c773e-a50a-7755-812e-5bb5b0ea9613" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019c773e-a50a-7098-91c9-15853272c3f8" xlink:to="loc_us-gaap_DerivativeLiabilities_019c773e-a50a-7755-812e-5bb5b0ea9613" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofComponentsofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#PROPERTYANDEQUIPMENTScheduleofComponentsofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofComponentsofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ff3ec420-7f09-4528-bb0a-a0f48225d20c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_96c5c00a-42d6-41cc-b102-bced61f0c85a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ff3ec420-7f09-4528-bb0a-a0f48225d20c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_96c5c00a-42d6-41cc-b102-bced61f0c85a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_315b1c59-c391-4d53-92b4-30d313be209a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ff3ec420-7f09-4528-bb0a-a0f48225d20c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_315b1c59-c391-4d53-92b4-30d313be209a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIESDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#ACCRUEDLIABILITIESDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_74514b91-9580-4856-a5b9-b55b2d21313f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_74514b91-9580-4856-a5b9-b55b2d21313f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_AccruedOutsourcedManufacturingCurrent_dab3a261-1a4f-4369-9e3f-58b380d846a6" xlink:href="vrdn-20251231.xsd#vrdn_AccruedOutsourcedManufacturingCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_vrdn_AccruedOutsourcedManufacturingCurrent_dab3a261-1a4f-4369-9e3f-58b380d846a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_AccruedMilestonePaymentCurrent_37739574-707b-4723-b6cd-598bdbda315e" xlink:href="vrdn-20251231.xsd#vrdn_AccruedMilestonePaymentCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_vrdn_AccruedMilestonePaymentCurrent_37739574-707b-4723-b6cd-598bdbda315e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent_063dfa30-b412-4711-819e-ccbeaa05ab3f" xlink:href="vrdn-20251231.xsd#vrdn_AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_vrdn_AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent_063dfa30-b412-4711-819e-ccbeaa05ab3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_f81778b7-8c3b-49a8-8140-c7007148f83b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_f81778b7-8c3b-49a8-8140-c7007148f83b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aa7a505a-cdce-4563-80f8-3b9b2aaf4439" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aa7a505a-cdce-4563-80f8-3b9b2aaf4439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_007289f1-88e1-4130-a97c-93ea3667aac5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_007289f1-88e1-4130-a97c-93ea3667aac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_e6a3e05b-fba6-45e7-9dcc-8b50e51b8131" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_us-gaap_InterestPayableCurrent_e6a3e05b-fba6-45e7-9dcc-8b50e51b8131" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_84b9ac76-0ec1-4350-95b3-b14e43f306be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_ce9b51ba-8b20-4292-8784-c88c75706a5d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_84b9ac76-0ec1-4350-95b3-b14e43f306be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/DEBTScheduleofComponentsofTheAmendedTermLoanDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#DEBTScheduleofComponentsofTheAmendedTermLoanDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/DEBTScheduleofComponentsofTheAmendedTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4798cc28-f9bd-4308-adf5-d58e85e4c143" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_AccruedDebtFees_3e8b88ca-2d24-4ad6-b72c-8b42706ac10e" xlink:href="vrdn-20251231.xsd#vrdn_AccruedDebtFees"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4798cc28-f9bd-4308-adf5-d58e85e4c143" xlink:to="loc_vrdn_AccruedDebtFees_3e8b88ca-2d24-4ad6-b72c-8b42706ac10e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b3c3af70-e07e-4cb4-9812-3db2bdcd0549" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4798cc28-f9bd-4308-adf5-d58e85e4c143" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b3c3af70-e07e-4cb4-9812-3db2bdcd0549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_019c6d1b-7238-7864-b302-e1a721e47f94" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4798cc28-f9bd-4308-adf5-d58e85e4c143" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_019c6d1b-7238-7864-b302-e1a721e47f94" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/DEBTScheduleofFuturePrincipalPaymentsofDebtDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#DEBTScheduleofFuturePrincipalPaymentsofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/DEBTScheduleofFuturePrincipalPaymentsofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_79b88324-33a8-4d14-b5f7-742b6d408c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6000871c-43c9-437f-bd86-4af4ecf38e13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_79b88324-33a8-4d14-b5f7-742b6d408c4a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6000871c-43c9-437f-bd86-4af4ecf38e13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1617f544-7535-4c7a-9673-a684ac5e4ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_79b88324-33a8-4d14-b5f7-742b6d408c4a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1617f544-7535-4c7a-9673-a684ac5e4ddb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6aacc097-c3e7-4ad0-bfdb-614006cb4e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_79b88324-33a8-4d14-b5f7-742b6d408c4a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6aacc097-c3e7-4ad0-bfdb-614006cb4e8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_965dc51e-2879-4419-8478-ef891222bd12" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_79b88324-33a8-4d14-b5f7-742b6d408c4a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_965dc51e-2879-4419-8478-ef891222bd12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_019c6c17-ab7b-7c82-834a-5a9a45f09dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_79b88324-33a8-4d14-b5f7-742b6d408c4a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_019c6c17-ab7b-7c82-834a-5a9a45f09dd3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5917aba6-b2fe-4fcf-a366-ac65c61f0458" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8db539b1-3cf5-402e-85b1-1d562ad4fe7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5917aba6-b2fe-4fcf-a366-ac65c61f0458" xlink:to="loc_us-gaap_OperatingLeaseLiability_8db539b1-3cf5-402e-85b1-1d562ad4fe7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3964992a-9d54-4749-a8bc-281f190fb44c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5917aba6-b2fe-4fcf-a366-ac65c61f0458" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3964992a-9d54-4749-a8bc-281f190fb44c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails_1" xlink:type="simple" xlink:href="vrdn-20251231.xsd#COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_87b4f902-09ef-4b82-b4a7-309394fda10c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_58b003b5-4579-42af-af18-cabcade44cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_87b4f902-09ef-4b82-b4a7-309394fda10c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_58b003b5-4579-42af-af18-cabcade44cd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_46f1780f-5c1e-498b-ab1d-f2aaf6492c03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_87b4f902-09ef-4b82-b4a7-309394fda10c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_46f1780f-5c1e-498b-ab1d-f2aaf6492c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_39b33283-47ec-4a57-8c1d-345b5196152d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_87b4f902-09ef-4b82-b4a7-309394fda10c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_39b33283-47ec-4a57-8c1d-345b5196152d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5702bf36-777f-4aac-a85d-964b92874ada" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_87b4f902-09ef-4b82-b4a7-309394fda10c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5702bf36-777f-4aac-a85d-964b92874ada" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019c6c76-6b36-7063-ae61-fab46934104d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c6c76-6b36-741c-b426-3983d55425a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c6c76-6b36-7063-ae61-fab46934104d" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_019c6c76-6b36-741c-b426-3983d55425a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019c6c76-6b36-76e2-953d-9bdfbbe72d84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c6c76-6b36-7063-ae61-fab46934104d" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_019c6c76-6b36-76e2-953d-9bdfbbe72d84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c6c76-6b36-768d-9dd2-8e133ec639dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c6c76-6b36-7063-ae61-fab46934104d" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c6c76-6b36-768d-9dd2-8e133ec639dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_019c6c76-6b36-7118-9d11-9fe257b3e2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c6c76-6b36-7063-ae61-fab46934104d" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_019c6c76-6b36-7118-9d11-9fe257b3e2bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019c6c76-6b36-789c-8059-b4c299bea733" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_019c6c76-6b36-7063-ae61-fab46934104d" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_019c6c76-6b36-789c-8059-b4c299bea733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0140dfbd-5280-4118-8370-187969158fda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0140dfbd-5280-4118-8370-187969158fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_54fc075d-cdfd-4ece-a653-87cf29ad8615" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_54fc075d-cdfd-4ece-a653-87cf29ad8615" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c6c73-4970-7943-a53e-60b86142cf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_019c6c73-4970-7943-a53e-60b86142cf1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_019c6c73-7bf4-78f6-822c-b6b1fcd0a1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_019c6c73-7bf4-78f6-822c-b6b1fcd0a1d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1a02b116-660e-44b8-969f-61ab104c904d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_1a02b116-660e-44b8-969f-61ab104c904d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_1960d0cb-eb8a-45b3-8add-901ef5b190f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_1960d0cb-eb8a-45b3-8add-901ef5b190f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019c6c72-acfc-7437-a94b-dddf23c1b564" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_019c6c72-acfc-7437-a94b-dddf23c1b564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019c6c72-acfc-797d-9451-3ed10f28ad58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f793934a-baeb-47a5-abba-6442c4bc6668" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_019c6c72-acfc-797d-9451-3ed10f28ad58" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a6432af6-a95b-4cdf-bd66-32bbe5668e44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a6432af6-a95b-4cdf-bd66-32bbe5668e44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f1189b9d-5c80-4765-9684-0f1a8df3deff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_f1189b9d-5c80-4765-9684-0f1a8df3deff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_9f2d8ed1-6a2d-450c-8aee-1f21f47d4d75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_9f2d8ed1-6a2d-450c-8aee-1f21f47d4d75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6e6fd1e5-2b01-4923-90bc-b5e616e80832" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6e6fd1e5-2b01-4923-90bc-b5e616e80832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_DeferredTaxAssetsTaxDeferredExpenseStartUpCostsAndAmortizedCosts_bdd9045e-9a21-4ab9-9df2-ecfc7cdea37a" xlink:href="vrdn-20251231.xsd#vrdn_DeferredTaxAssetsTaxDeferredExpenseStartUpCostsAndAmortizedCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_vrdn_DeferredTaxAssetsTaxDeferredExpenseStartUpCostsAndAmortizedCosts_bdd9045e-9a21-4ab9-9df2-ecfc7cdea37a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_d53f0f45-1183-47c4-a4ba-b42afc6b16e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_d53f0f45-1183-47c4-a4ba-b42afc6b16e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_DeferredTaxAssetsOperatingLeaseRightOfUseAssetNet_8adfe4f4-d804-45a7-a3b0-776ec275caee" xlink:href="vrdn-20251231.xsd#vrdn_DeferredTaxAssetsOperatingLeaseRightOfUseAssetNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_vrdn_DeferredTaxAssetsOperatingLeaseRightOfUseAssetNet_8adfe4f4-d804-45a7-a3b0-776ec275caee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_01471756-075f-4629-8bed-6b37d7f41137" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_01471756-075f-4629-8bed-6b37d7f41137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_DeferredTaxAssetsSaleOfFutureRevenues_019c6c7a-7e27-78c8-8f5d-e726e5ce7f97" xlink:href="vrdn-20251231.xsd#vrdn_DeferredTaxAssetsSaleOfFutureRevenues"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_dde1987c-ca72-419e-a172-2c35c331464a" xlink:to="loc_vrdn_DeferredTaxAssetsSaleOfFutureRevenues_019c6c7a-7e27-78c8-8f5d-e726e5ce7f97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_460db004-8477-473e-a3e7-8d99e1f5e554" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0b2bb3de-02a4-42eb-8ae1-2d5d7f829845" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_460db004-8477-473e-a3e7-8d99e1f5e554" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_0b2bb3de-02a4-42eb-8ae1-2d5d7f829845" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8649d784-092f-4c34-8b53-3431f36a8783" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_460db004-8477-473e-a3e7-8d99e1f5e554" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8649d784-092f-4c34-8b53-3431f36a8783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f4542e9f-fdc9-4198-a0cf-a19d65dd77d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5a07817d-f155-40ed-a336-d66c6863c80b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f4542e9f-fdc9-4198-a0cf-a19d65dd77d7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5a07817d-f155-40ed-a336-d66c6863c80b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_05ad0116-6b82-468b-8134-ba08f1c3a7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_f4542e9f-fdc9-4198-a0cf-a19d65dd77d7" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_05ad0116-6b82-468b-8134-ba08f1c3a7d7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="vrdn-20251231.xsd#SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_cf90d3f8-ad8c-4eca-97c5-65f06a9e1cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3e1aa96-1d8f-4338-9942-6141b22e88cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_cf90d3f8-ad8c-4eca-97c5-65f06a9e1cf2" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3e1aa96-1d8f-4338-9942-6141b22e88cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense_5fc38e1f-2b52-4652-b7ce-0175f56d0c75" xlink:href="vrdn-20251231.xsd#vrdn_SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_cf90d3f8-ad8c-4eca-97c5-65f06a9e1cf2" xlink:to="loc_vrdn_SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense_5fc38e1f-2b52-4652-b7ce-0175f56d0c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense_fe94ecd6-b1dd-417f-b07f-f203f37318be" xlink:href="vrdn-20251231.xsd#vrdn_ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_cf90d3f8-ad8c-4eca-97c5-65f06a9e1cf2" xlink:to="loc_vrdn_ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense_fe94ecd6-b1dd-417f-b07f-f203f37318be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_29c3990d-48d4-4bb6-8c5e-477304b86e14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_36fd1155-f772-4316-9e96-8cc179d54432" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_29c3990d-48d4-4bb6-8c5e-477304b86e14" xlink:to="loc_us-gaap_OperatingExpenses_36fd1155-f772-4316-9e96-8cc179d54432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4ff0fab3-473a-423e-aba8-4a1075cb09a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_29c3990d-48d4-4bb6-8c5e-477304b86e14" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4ff0fab3-473a-423e-aba8-4a1075cb09a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_47240ad5-532d-48ce-8694-e0a7d8c8a9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_29c3990d-48d4-4bb6-8c5e-477304b86e14" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_47240ad5-532d-48ce-8694-e0a7d8c8a9ae" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
